X27R3TADilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
- Billable / Specific Code
X27R3TA is a billable ICD-10-PCS procedure code for Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 252, 253, 254. The root operation Dilation involves expanding an orifice or the lumen of a tubular body part. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Angioplasty and related vessel procedures (endovascular; excluding carotid).
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | 7 | Dilation |
| 4 | BodyPart | R | Posterior Tibial Artery, Right |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | T | Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s) |
| 7 | Qualifier | A | New Technology Group 10 |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Code History
Similar Procedure Codes
Questions About X27R3TA
Is X27R3TA a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in X27R3TA mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character 7 is the Operation (Dilation); the 4th character R is the BodyPart (Posterior Tibial Artery, Right); the 5th character 3 is the Approach (Percutaneous); the 6th character T is the Device/Substance/Technology (Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s)); the 7th character A is the Qualifier (New Technology Group 10).
What MS-DRG does X27R3TA group to?
On an inpatient stay, Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10 maps to MS-DRGs 252, 253, 254, with relative weights from 1.7961 to 3.4822. The MS-DRG sets the fixed Medicare payment for the stay.